// App-Quantinova.ai

1129 : Thromboembolism and Clinically Relevant Bleeding in Relation to Warfarin Anticoagulation Variability in Patients Monitored with Either Fiix-Prothrombin Time or Quick-Prothrombin Time. the Fiix-Trial

Researchers

Presenter

  • Alma R. Oskarsdottir

Principal Investigators

  • Brynja R. Gudmundsdottir

  • Olafur S. Indridason

  • Hulda M. Jensdottir

  • David O. Arnar

  • Einar S. Bjornsson

  • Magnus K. Magnusson

  • Sigrun H. Lund

  • Brynjar Vidarsson

  • Charles W. Francis

  • Pall T. Onundarson

Medical Centers

  • Landspitali Unversity Hospital, Reykjavik, Iceland

  • Faculty of Medicine, University of Iceland School of Health Sciences, Reykjavik, Iceland

  • University of Rochester Medcal Center, Rochester, NY

Locations

  • United States

  • Iceland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Transthyretin

Drug/Treatment

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved